Drug

Who makes valganciclovir?

13 companies list valganciclovir as a human prescription drug, including under the names Valcyte. Forms: for solution; powder, for solution; tablet; tablet, film coated. Routes: oral.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing valganciclovir

CompanyFormsApplicationNDCsRegistered sites
Dr. Reddy's Laboratories LimitedIndiatablet, film coatedANDAANDA203511115
Granules Pharmaceuticals Inc.Indiafor solutionANDAANDA21330618
Micro Labs LimitedIndiapowder, for solutionANDAANDA21883815
Pharma Packaging Solutions, LLC dba Tjoapack, LLCUnited Statestablet, film coatedANDAANDA20351115
Ajanta Pharma LimitedIndiatabletANDAANDA21223412
AIRIS PHARMA PRIVATE LIMITEDIndiafor solutionANDAANDA21016911
Camber Pharmaceuticals, Inc.United Statestablet, film coatedANDAANDA20516611
Florida Pharmaceutical Products LLCUnited Statespowder, for solutionANDAANDA21631711
Golden State Medical Supply Inc.United Statestablet, film coatedANDAANDA20351111
Somerset Therapeutics Private LimitedIndiafor solutionANDAANDA21330611
AvPAKtablet, film coatedANDAANDA20516610
H2-Pharma, LLCtablet, film coatedNDANDA02130410
MAJOR Pharmaceuticals Inc.tablet, film coatedANDAANDA20516610
Enquiry

Common questions

Who makes valganciclovir?
13 companies list valganciclovir as a human prescription drug in the openFDA NDC Directory, led by Dr. Reddy's Laboratories Limited, Granules Pharmaceuticals Inc., Micro Labs Limited, Pharma Packaging Solutions, LLC dba Tjoapack, LLC, Ajanta Pharma Limited. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Is there a generic Valcyte?
12 companies list valganciclovir under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.